PT  - JOURNAL ARTICLE
AU  - Deise Mara M. Mattos
AU  - Maria Luisa Gomes
AU  - Rosimeire S. Freitas
AU  - Edson M. Boasquevisque
AU  - Valbert N. Cardoso
AU  - Emílio F. Paula
AU  - Mario Bernardo-Filho
TI  - The Effect of Vincristine on the Biodistribution of Technetium-99m DTPA, GHA, and DMSA in Balb/c Female Mice
DP  - 2000 Dec 01
TA  - Journal of Nuclear Medicine Technology
PG  - 271--274
VI  - 28
IP  - 4
4099  - http://tech.snmjournals.org/content/28/4/271.short
4100  - http://tech.snmjournals.org/content/28/4/271.full
SO  - J. Nucl. Med. Technol.2000 Dec 01; 28
AB  - Objective: Vincristine has been widely used in various chemotherapeutic protocols in oncology. The purpose of this study was to evaluate the effect of vincristine on the biodistribution of 99mTc-DMSA, 99mTc-GHA, and 99mTc-DTPA in Balb/c female mice. Methods: Vincristine (0.03 mg, 0.3 mL) was injected into female isogenic Balb/c mice (n = 15), in 3 doses over an interval of 96 h. The 99mTc-DMSA, 99mTc-GHA, or 99mTc-DTPA (7.4 MBq) was administered after the last dose of vincristine. After 0.5 h the animals were killed rapidly. The organs (pancreas, thyroid, brain, thymus, ovary, uterus, spleen, kidney, heart, stomach, lung, liver, bone, and lymph nodes) were isolated and the radioactivity in each organ was counted in a NaI(Tl) well counter. The percentage of radioactivity (%) in each was calculated and compared with the control group. Statistical analysis was performed by Wilcoxon test (P < 0.05). Results: The percentage of 99mTc-DMSA was increased in the lung, pancreas, heart, thyroid, brain, bone, and lymph nodes (inguinal and mesenteric). The percentage of 99mTc-GHA was decreased in the uterus, ovary, spleen, thymus, lymph nodes (inguinal and mesenteric), kidney, and heart. The percentage of 99mTc-DTPA was increased in thymus, lymph nodes (inguinal and mesenteric), ovary, uterus, spleen, kidney, heart, stomach, lung, liver, and bone. Conclusion: The results could be explained by the metabolization, toxic effect, therapeutic, or immunosupressive action of the studied chemotherapeutic drug.